Lipid rafts regulate lipopolysaccharide-induced activation of Cdc42 and inflammatory functions of the human neutrophil.
Michael B Fessler, Patrick G Arndt, S Courtney Frasch...
https://pubmed.ncbi.nlm.nih.gov/15262974/Actively Recruiting
Led by National Institute of Environmental Health Sciences (NIEHS) · Updated on 2026-09-28
750
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are investigating how certain white blood cells, including neutrophils, monocytes, eosinophils, and lymphocytes, respond to various signals in laboratory settings. The study aims to understand how these cells sense signals in the body, what substances they produce, and how they may contribute to inflammation. It also measures substances in blood plasma that might stimulate white blood cells to learn how blood responds to possible disease-related conditions. Participants donate whole blood samples, which are separated into components such as neutrophils, red blood cells, mononuclear cells, and plasma. These cells are exposed to inflammatory stimuli like lipopolysaccharide LPS to study signaling pathways and inflammatory responses in vitro. The study also explores the role of lipid raft membrane microdomains, the tumor suppressor gene p53, and zinc-finger proteins in regulating inflammation. Blood donations occur no more than once every 8 weeks, with up to six donations per year. Participants who are healthy adults aged 18 to 65 years and weigh at least 110 pounds provide blood samples in a monitored setting. The study includes testing for HIV, hepatitis B, and hepatitis C every 6 months to ensure safety and validity of results. Researchers analyze the cells responses to stimuli and measure various inflammatory functions. The study tracks signaling pathways activated by immune stimuli and evaluates functional consequences in white blood cells without further interventions.
CONDITIONS
Immune Cell Response to Stimuli
N
NIEHS Join A Study Recruitment Group
M
Michael B Fessler, M.D.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
National Institute of Environmental Health Sciences (NIEHS)
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 1 year
Participants provide blood samples up to six times a year, with at least 8 weeks between donations. The blood is separated into components and studied in the lab to understand immune cell responses.
Up to 6 visits per year
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Michael B Fessler, Patrick G Arndt, S Courtney Frasch...
https://pubmed.ncbi.nlm.nih.gov/15262974/S Courtney Frasch, Peter M Henson, Kaz Nagaosa...
https://pubmed.ncbi.nlm.nih.gov/14766753/Travis S Walker, Kerry L Tomlin, G Scott Worthen...
https://pubmed.ncbi.nlm.nih.gov/15908399/National Institute of Environmental Health Sciences (NIEHS)
Lead Sponsor